AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLYAgreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on August 7, 2017 ("Execution Date") by and between Thomas Donnelly ("Consultant"), a natural person whose address is at 44 Rue Bourgelat, 94700 Maisons-Alfort, FRANCE and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. ANDEmployment Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 21, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").
ContractBusiness Advisory Board Services Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
This Business Advisory Board Services Agreement (the “Agreement”), dated June 23, 2017, is entered into between Zander Therapeutics, Inc., a Nevada corporation (“the Company), and Brian Devine, an individual with a principal place of residence California(“Candidate”).
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 23, 2015 (the “Effective Date”), is made and entered into by and between Regen BioPharma Inc., an Nevada corporation (“Licensor”) and Zander Therapeutics Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. ANDEmployment Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 5, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS SECURITIES PURCHASE AGREEMENT (the ''Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the (“Company'') whose address is
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated September 12, 2017Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
ContractAgreement • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on March 20, 2017 (“Execution Date”) by and between Linda Black (“Consultant”), a natural person whose address is ___________and Entest BioMedical Inc.
AMENDED AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND JONATHAN BAELLAmended Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
Agreement made on August 16, 2017 ("Execution Date") by and between Jonathan Baell ("Consultant"), a natural person whose address is at 53 Glenard Drive, Eaglemont, VICTORIA 3084 Australia and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated June 15, 2016Agreement by And • October 4th, 2017 • Zander Therapeutics, Inc • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. ("ZANDER") AND ENTESTAgreement by and Between Zander • October 4th, 2017 • Zander Therapeutics, Inc
WHEREAS ENTEST paid $1,115 of incorporation expenses incurred in the incorporation of ZANDER on June 18, 2015("lncorporation Expenses")
ContractSecurities Purchase Agreement • October 4th, 2017 • Zander Therapeutics, Inc • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.
